期刊文献+

药师对直接抗病毒药物治疗患者的管理与实践

Pharmacist’s management and practice for patients treated with directacting antiviral agents
原文传递
导出
摘要 目的介绍我院药师对直接抗病毒药物(DAA)治疗患者的管理流程和实践成果,为国内药师对丙肝患者开展药学服务提供参考。方法我院建立医师将DAA治疗患者向药师转诊的流程,由药师协作完成对患者DAA治疗的药学监护。服务重点内容包括:识别并处理与DAA相关的药物相互作用和药物不良反应,开展用药依从性及丙肝再感染风险的教育、提醒和管理患者化验检查。结果2020年5月至2021年4月药师为189例转诊患者提供药学服务,服务过程中回答并解决患者用药问题443个,主要是药物不良反应(20.09%)以及药物相互作用(18.28%)。100%的患者对药师的服务感到非常满意。结论药师对DAA治疗患者开展药学服务可行有效,药师能够解决患者的用药问题并取得较高的患者满意度,体现了药师的专业价值。 AIM To introduce the management process and practical results of pharmacists in our hospital for the direct-acting antiviral agents(DAA)treatment of patients,and provide references for domestic pharmacists to carry out pharmacy services for hepatitis C patients.METHODS The process of referring DAA treated patients to pharmacists was established in our hospital,and the pharmacists collaborate to complete the pharmacy care of patients for DAA treatment.The focus of the service included on identifying and handling drug-drug interactions and adverse drug reactions related to DAA,carrying out education on medication compliance and the risk of hepatitis C reinfection,reminding and managing patient’s laboratory tests.RESULTS From May 2020 to April 2021,pharmacists provided pharmacy services to 189 referred patients.During the service,they answered and solved 443 medication problems,mainly due to adverse drug reactions(20.09%)and drug-drug interactions(18.28%).The 100%of patients were very satisfied with the services by pharmacists.CONCLUSION It is feasible and effective for pharmacists to carry out pharmacy services for patients treated with DAA.Pharmacists can solve patients’medication problems and achieve high patient’s satisfaction,which reflects the professional value of pharmacists.
作者 黄灿 高爱苹 郑永红 贾金梅 郭翠霞 朱晓虹 HUANG Can;GAO Aiping;ZHENG Yonghong;JIA Jinmei;GUO Cuixia;ZHU Xiaohong(Department of Pharmacy,Capital Medical University Affiliated Beijing Youan Hospital,Beijing 100069,China)
出处 《中国临床药学杂志》 CAS 2022年第3期197-201,共5页 Chinese Journal of Clinical Pharmacy
关键词 直接抗病毒药物 丙型肝炎病毒 药学门诊 药学服务 direct-acting antiviral agents hepatitis C virus pharmacy clinic pharmacy service
  • 相关文献

参考文献6

二级参考文献37

  • 1饶慧瑛,郭芳,魏来.2005年美国肝病学会急性肝衰竭诊治和肝移植患者评价指南简介[J].中华肝脏病杂志,2006,14(2):154-156. 被引量:22
  • 2Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association.肝衰竭诊疗指南[J].中华肝脏病杂志,2006,14(9):643-646. 被引量:828
  • 3F. Poordad,D. Dieterich.Treating hepatitis C: current standard of care and emerging direct‐acting antiviral agents[J].Journal of Viral Hepatitis.2012(7)
  • 4Joseph F. Perz,Gregory L. Armstrong,Leigh A. Farrington,Yvan J.F. Hutin,Beth P. Bell.The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide[J].Journal of Hepatology.2006(4)
  • 5Nezam Afdhal,Stefan Zeuzem,Paul Kwo,Mario Chojkier,Norman Gitlin,Massimo Puoti,Manuel Romero-Gomez,Jean-Pierre Zarski,Kosh Agarwal,Peter Buggisch,Graham R. Foster,Norbert Br?u,Maria Buti,Ira M. Jacobson,G. Mani Subramanian,Xiao Ding,Hongmei Mo,Jenny C. Yang,Phillip S. Pang,William T. Symonds,John G. McHutchison,Andrew J. Muir,Alessandra Mangia,Patrick Marcellin.??Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection(J)The New England Journal of Medicine . 2014 (20)
  • 6M.S. Sulkowski,H.E. Vargas,A.M. Di Bisceglie,P.A. Kuo,K.R. Reddy,J.K. Lim,G. Morelli,J.M. Darling,J.J. Feld,R.S. Brown,L.M. Frazier,T.G. Stewart,M.W. Fried,D.R. Nelson,I.M. Jacobson.??Effectiveness of Simeprevir plus Sofosbuvir, With or Without Ribavirin, in Real-World Patients with HCV Genotype 1 Infection(J)Gastroenterology . 2015
  • 7Marie-Louise Vachon,Douglas Dieterich.??The Era of Direct-Acting Antivirals Has Begun: The Beginning of the End for HCV?(J)Semin Liver Dis . 2011 (04)
  • 8M. H. Miller,K. Agarwal,A. Austin,A. Brown,S. T. Barclay,P. Dundas,G. M. Dusheiko,G. R. Foster,R. Fox,P. C. Hayes,C. Leen,C. Millson,S. D. Ryder,J. Tait,A. Ustianowski,J. F. Dillon.??Review article: 2014 UK consensus guidelines – hepatitis C management and direct‐acting anti‐viral therapy(J)Aliment Pharmacol Ther . 2014 (12)
  • 9Eric M. Yoshida,Mark S. Sulkowski,Edward J. Gane,Robert W. Herring,Vlad Ratziu,Xiao Ding,Jing Wang,Shu‐Min Chuang,Julie Ma,John McNally,Luisa M. Stamm,Diana M. Brainard,William T. Symonds,John G. McHutchison,Kimberly L. Beavers,Ira M. Jacobson,K. Rajender Reddy,Eric Lawitz.??Concordance of sustained virological response 4, 12, and 24 weeks post‐treatment with sofosbuvir‐containing regimens for hepatitis C virus(J)Hepatology . 2015 (1)
  • 10Robert G. Gish,Chari A. Cohen,Joan M. Block,Carol L. Brosgart,Timothy M. Block,Ryan Clary,Loc T. Le,Michael H. Ninburg,Lorren Sandt,Kris V. Kowdley.??Data supporting updating estimates of the prevalence of chronic hepatitis B and C in the United States(J)Hepatology . 2015 (5)

共引文献458

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部